Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 68

1.

Peptide mimotopes selected from a random peptide library for diagnosis of Epstein-Barr virus infection.

Casey JL, Coley AM, Street G, Parisi K, Devine PL, Foley M.

J Clin Microbiol. 2006 Mar;44(3):764-71.

2.

Evaluation of a novel commercial enzyme-linked immunosorbent assay detecting Coxiella burnetii-specific immunoglobulin G for Q fever prevaccination screening and diagnosis.

Field PR, Santiago A, Chan SW, Patel DB, Dickeson D, Mitchell JL, Devine PL, Murphy AM.

J Clin Microbiol. 2002 Sep;40(9):3526-9.

3.

Use of recombinant envelope proteins for serological diagnosis of Dengue virus infection in an immunochromatographic assay.

Cuzzubbo AJ, Endy TP, Nisalak A, Kalayanarooj S, Vaughn DW, Ogata SA, Clements DE, Devine PL.

Clin Diagn Lab Immunol. 2001 Nov;8(6):1150-5.

4.

Early diagnosis of scrub typhus with a rapid flow assay using recombinant major outer membrane protein antigen (r56) of Orientia tsutsugamushi.

Ching WM, Rowland D, Zhang Z, Bourgeois AL, Kelly D, Dasch GA, Devine PL.

Clin Diagn Lab Immunol. 2001 Mar;8(2):409-14.

5.
6.
7.

Evaluation of a new commercially available immunoglobulin M and immunoglobulin G immunochromatographic test for diagnosis of melioidosis infection.

Cuzzubbo AJ, Chenthamarakshan V, Vadivelu J, Puthucheary SD, Rowland D, Devine PL.

J Clin Microbiol. 2000 Apr;38(4):1670-1.

8.

Comparison of a commercial enzyme-linked immunosorbent assay with immunofluorescence and complement fixation tests for detection of Coxiella burnetii (Q fever) immunoglobulin M.

Field PR, Mitchell JL, Santiago A, Dickeson DJ, Chan SW, Ho DW, Murphy AM, Cuzzubbo AJ, Devine PL.

J Clin Microbiol. 2000 Apr;38(4):1645-7.

9.

Comparison of PanBio Dengue Duo IgM and IgG capture ELISA and venture technologies dengue IgM and IgG dot blot.

Cuzzubbo AJ, Vaughn DW, Nisalak A, Solomon T, Kalayanarooj S, Aaskov J, Dung NM, Devine PL.

J Clin Virol. 2000 Apr;16(2):135-44.

PMID:
10720818
10.

Evaluation of a new commercially available immunoglobulin M capture enzyme-linked immunosorbent assay for diagnosis of Japanese encephalitis infections.

Cuzzubbo AJ, Endy TP, Vaughn DW, Solomon T, Nisalak A, Kalayanarooj S, Dung NM, Warrilow D, Aaskov J, Devine PL.

J Clin Microbiol. 1999 Nov;37(11):3738-41.

11.

Comparison of PanBio dengue duo enzyme-linked immunosorbent assay (ELISA) and MRL dengue fever virus immunoglobulin M capture ELISA for diagnosis of dengue virus infections in Southeast Asia.

Cuzzubbo AJ, Vaughn DW, Nisalak A, Solomon T, Kalayanarooj S, Aaskov J, Dung NM, Devine PL.

Clin Diagn Lab Immunol. 1999 Sep;6(5):705-12.

12.

Serum mucin antigen (CASA) as a marker of amiodarone-induced pulmonary toxicity.

Devine PL, Siebert WJ, Morton SL, Scells B, Quin RJ, Heddle WF, Zimmerman PV, Donohoe PJ.

Dis Markers. 1998 Nov;14(3):169-75.

13.

Rapid serologic diagnosis of dengue virus infection using a commercial capture ELISA that distinguishes primary and secondary infections.

Vaughn DW, Nisalak A, Solomon T, Kalayanarooj S, Nguyen MD, Kneen R, Cuzzubbo A, Devine PL.

Am J Trop Med Hyg. 1999 Apr;60(4):693-8.

PMID:
10348250
14.

Glycoprotein detection of 2-D separated proteins.

Packer NH, Ball MS, Devine PL.

Methods Mol Biol. 1999;112:341-52. Review. No abstract available.

PMID:
10027260
15.

Monoclonal antibody recognizing a core epitope on mucin.

Devine PL, Quin RJ, Shield PW, Liew YW, Sheehan JK, Thornton DJ.

Dis Markers. 1998 Oct;14(2):99-112.

16.

Detection of specific antibodies in saliva during dengue infection.

Cuzzubbo AJ, Vaughn DW, Nisalak A, Suntayakorn S, Aaskov J, Devine PL.

J Clin Microbiol. 1998 Dec;36(12):3737-9.

17.

Antibodies reactive with the protein core of MUC1 mucin are present in ovarian cancer patients and healthy women.

Richards ER, Devine PL, Quin RJ, Fontenot JD, Ward BG, McGuckin MA.

Cancer Immunol Immunother. 1998 Jul;46(5):245-52.

PMID:
9690452
19.

Comparison of commercial ELISA for detection of antibodies to the viral capsid antigen (VCA) of Epstein-Barr virus (EBV).

Mitchell JL, Doyle CM, Land MV, Devine PL.

Dis Markers. 1998 Feb;13(4):245-9. Review. No abstract available.

20.

Coexpression of MUC1 mucin peptide core and the Thomsen-Friedenreich antigen in colorectal neoplasms.

Baldus SE, Hanisch FG, Kotlarek GM, Zirbes TK, Thiele J, Isenberg J, Karsten UR, Devine PL, Dienes HP.

Cancer. 1998 Mar 15;82(6):1019-27.

PMID:
9506345
21.

Evaluation of a rapid immunochromatographic test for diagnosis of dengue virus infection.

Vaughn DW, Nisalak A, Kalayanarooj S, Solomon T, Dung NM, Cuzzubbo A, Devine PL.

J Clin Microbiol. 1998 Jan;36(1):234-8.

23.

Serum cytokines and tumour markers in patients with non-small cell carcinoma of the lung.

Bansal AS, Bruce J, Devine PL, Scells B, Zimmermann PV.

Dis Markers. 1997 Nov;13(3):195-9.

PMID:
9405932
25.

Evaluation of four commercial enzyme immunoassays for detection of immunoglobulin M antibodies to human parvovirus B19.

Sloots T, Devine PL.

Eur J Clin Microbiol Infect Dis. 1996 Sep;15(9):758-61.

PMID:
8922581
26.
27.

Respiratory mucins: identification of core proteins and glycoforms.

Thornton DJ, Carlstedt I, Howard M, Devine PL, Price MR, Sheehan JK.

Biochem J. 1996 Jun 15;316 ( Pt 3):967-75.

28.

Evaluation of a commercial enzyme-linked immunosorbent assay for detection of serum immunoglobulin G response to human herpesvirus 6.

Sloots TP, Kapeleris JP, Mackay IM, Batham M, Devine PL.

J Clin Microbiol. 1996 Mar;34(3):675-9.

29.

Early steps in the biosynthesis of MUC2 epithelial mucin in colon cancer cells.

McGuckin MA, Devine PL, Ward BG.

Biochem Cell Biol. 1996;74(1):87-93.

PMID:
9035693
30.

Prostate-specific antigen (PSA) and cancer-associated serum antigen (CASA) in distinguishing benign and malignant prostate disease.

Devine PL, Walsh MD, McGuckin MA, Quin RJ, Hohn BG, Clague A, Samaratunga H.

Int J Biol Markers. 1995 Oct-Dec;10(4):221-5.

PMID:
8750649
31.

MUC1 in secretory phase endometrium: expression in precisely dated biopsies and flushings from normal and recurrent miscarriage patients.

Hey NA, Li TC, Devine PL, Graham RA, Saravelos H, Aplin JD.

Hum Reprod. 1995 Oct;10(10):2655-62.

PMID:
8567787
32.

Monoclonal antibodies recognising sialyl-Tn: production and application to immunochemistry.

Devine PL, Birrell GW, Quin RJ, Shield PW.

Dis Markers. 1995 Aug;12(3):175-86.

PMID:
8590544
33.

Production of CEA-reactive monoclonal antibody (4E7) and its applications in immunochemistry.

Devine PL, Birrell GW, Quin RJ, Hayman J, Shield PW.

Hybridoma. 1995 Aug;14(4):397-9. No abstract available.

PMID:
8522353
34.

CA15-3, CASA, MSA, and TPS as diagnostic serum markers in breast cancer.

Devine PL, Duroux MA, Quin RJ, McGuckin MA, Joy GJ, Ward BG, Pollard CW.

Breast Cancer Res Treat. 1995 Jun;34(3):245-51.

PMID:
7579489
35.

Predictive value of the combination of serum markers, CA125, CASA and TPS in ovarian cancer.

Devine PL, McGuckin MA, Quin RJ, Ward BG.

Int J Gynecol Cancer. 1995 May;5(3):170-178.

PMID:
11578473
36.

Methods for separation and deglycosylation of mucin subunits.

Thornton DJ, Howard M, Devine PL, Sheehan JK.

Anal Biochem. 1995 May 1;227(1):162-7.

PMID:
7668377
37.

All cytokeratin assays are not the same.

Devine PL.

Eur J Clin Chem Clin Biochem. 1994 Dec;32(12):939-40. No abstract available.

PMID:
7535108
38.

Keratinocyte growth factor induces proliferation of hepatocytes and epithelial cells throughout the rat gastrointestinal tract.

Housley RM, Morris CF, Boyle W, Ring B, Biltz R, Tarpley JE, Aukerman SL, Devine PL, Whitehead RH, Pierce GF.

J Clin Invest. 1994 Nov;94(5):1764-77.

39.

Screening and monitoring coeliac disease: multicentre trial of a new serum antibody test kit.

Devine PL, Birrell GW, Golder JP, Marsh MN, Morgan S, Chang G, Gillis D, Hobson P, Robertson P, Whybin R, et al.

Dis Markers. 1994 Oct;12(1):71-80.

PMID:
7842632
40.

Identification of two major populations of mucins in respiratory secretions.

Thornton DJ, Devine PL, Hanski C, Howard M, Sheehan JK.

Am J Respir Crit Care Med. 1994 Sep;150(3):823-32.

PMID:
8087358
41.

Use of plasma in serum tumour marker assays: cancer-associated serum antigen and mammary serum antigen.

Devine PL, Quin RJ.

Eur J Clin Chem Clin Biochem. 1994 Aug;32(8):629-30. No abstract available.

PMID:
7819434
42.

Monoclonal antibodies reacting with the mucin-specific lectin from Sambucus sieboldiana (SSA-M).

Devine PL, Quin RJ, Harada H.

Hybridoma. 1994 Aug;13(4):323-5.

PMID:
7806254
43.

Mucin expression by transitional cell carcinomas of the bladder.

Walsh MD, Hohn BG, Thong W, Devine PL, Gardiner RA, Samaratunga ML, McGuckin MA.

Br J Urol. 1994 Mar;73(3):256-62.

PMID:
8162502
44.

Factors effecting the measurement of tumor-associated MUC1 mucins in serum.

McGuckin MA, Devine PL, Ramm LE, Ward BG.

Tumour Biol. 1994;15(1):33-44.

PMID:
8146528
45.

Serum markers CASA and CA 15-3 in ovarian cancer: all MUC1 assays are not the same.

Devine PL, McGuckin MA, Quin RJ, Ward BG.

Tumour Biol. 1994;15(6):337-44.

PMID:
7997805
46.

Markers for metastatic adenocarcinoma in serous effusion specimens.

Shield PW, Callan JJ, Devine PL.

Diagn Cytopathol. 1994;11(3):237-45.

PMID:
7532566
47.

Peptide binding sites recognized by anti-mucin (MUC2) monoclonal antibodies.

Xing PX, Apostolopoulos V, Prenzoska J, Devine PL, McKenzie IF.

Scand J Immunol. 1993 Dec;38(6):591-2.

PMID:
7504828
48.

Expression of MUC2 epithelial mucin in breast carcinoma.

Walsh MD, McGuckin MA, Devine PL, Hohn BG, Wright RG.

J Clin Pathol. 1993 Oct;46(10):922-5.

49.
50.

The use of mucin-specific monoclonal antibodies and lectins in the detection of tumor-associated serum markers in gynecological cancer.

Devine PL, McGuckin MA, Ramm LE, Harada H, Ward BG.

Cancer Biochem Biophys. 1993 Sep;13(4):221-38.

PMID:
8521372

Supplemental Content

Loading ...
Support Center